ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines.

Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon.
With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.

Biotechnology

ProBioGen AG

Ingo Jordan

Julian Collins

Jana Windt

Claudia Conert

Dr. Sascha Ramm

Lukas Rositzka

Tanja Arnouk

Anastasia Piltsi

Christian Auerbach

Dirk Matthias

Kevin Pommerencke

Stefan Schulz

Tim Wonnecke

Christian Herrberger

Holger Bernhardt

Michiel Stork

Andrea Naujoks

Andrea Hauptmann

Katharina Vogdt

Rita Bhattacherjee

The Leadership Team at ProBioGen AG is responsible for steering the company’s strategic direction and ensuring organizational growth and excellence. This team, comprising the Vice President Vaccine Strategies, Senior Vice President People & Organizational Development, Vice President Business Development, and CFO, collaborates to oversee vaccine innovation and strategies, foster talent and organizational health, drive business growth and client relationships, and manage financial health and sustainability.

Leadership Team

Scientists and Researchers

Production and Development

Engineering and Process Development

Leadership Team

About

Team members

Other teams at ProBioGen AG

Scientists and Researchers

Production and Development

Engineering and Process Development